Literature DB >> 25042754

New advances in precision medicine for hepatocellular carcinoma recurrence prediction and treatment.

Silvia Vilarinho1, Diego F Calvisi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25042754     DOI： 10.1002/hep.27311

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  13 in total

Review 1.  Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.

Authors:  Yuan-Chi Teng; Zhao-Qing Shen; Cheng-Heng Kao; Ting-Fen Tsai
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study.

Authors:  Hong Wei; Hanyu Jiang; Yun Qin; Yuanan Wu; Jeong Min Lee; Fang Yuan; Tianying Zheng; Ting Duan; Zhen Zhang; Yali Qu; Jie Chen; Yuntian Chen; Zheng Ye; Shan Yao; Lin Zhang; Ting Yang; Bin Song
Journal:  Eur Radiol       Date:  2022-05-13       Impact factor: 5.315

3.  [Three-dimensional visualization combined with indocyanine green fluorescence imaging in diagnosis and treatment of primary hepatocellular carcinoma].

Authors:  Silue Zeng; Ning Zeng; Wen Zhu; Nan Xiang; Jian Yang; Sai Wen; Chihua Fang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-12-30

4.  Prognostic value of DNA repair based stratification of hepatocellular carcinoma.

Authors:  Zhuo Lin; Shi-Hao Xu; Hai-Qing Wang; Yi-Jing Cai; Li Ying; Mei Song; Yu-Qun Wang; Shan-Jie Du; Ke-Qing Shi; Meng-Tao Zhou
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

5.  Prognostic significance of miR-1268a expression and its beneficial effects for post-operative adjuvant transarterial chemoembolization in hepatocellular carcinoma.

Authors:  Yun-Long Lu; Jin-Guang Yao; Xiao-Ying Huang; Chao Wang; Xue-Min Wu; Qiang Xia; Xi-Dai Long
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

6.  Prognostic significance of Cbx4 expression and its beneficial effect for transarterial chemoembolization in hepatocellular carcinoma.

Authors:  H-K Jiao; Y Xu; J Li; W Wang; Z Mei; X-D Long; G-Q Chen
Journal:  Cell Death Dis       Date:  2015-03-12       Impact factor: 8.469

7.  Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity.

Authors:  Jie-Yi Shi; Qingfeng Xing; Meng Duan; Zhi-Chao Wang; Liu-Xiao Yang; Ying-Jun Zhao; Xiao-Ying Wang; Yun Liu; Minghua Deng; Zhen-Bin Ding; Ai-Wu Ke; Jian Zhou; Jia Fan; Ya Cao; Jiping Wang; Ruibin Xi; Qiang Gao
Journal:  Oncotarget       Date:  2016-01-19

8.  A novel RNA sequencing-based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma.

Authors:  Fumao Bai; Huaibin Zhou; Mengni Ma; Chen Guan; Jianxin Lyu; Qing H Meng
Journal:  Mol Oncol       Date:  2018-05-21       Impact factor: 6.603

9.  In silico identification of EP400 and TIA1 as critical transcription factors involved in human hepatocellular carcinoma relapse.

Authors:  Weiguo Hong; Yan Hu; Zhenping Fan; Rong Gao; Ruichuang Yang; Jingfeng Bi; Jun Hou
Journal:  Oncol Lett       Date:  2019-12-02       Impact factor: 2.967

10.  Prognostic significance of XRCC4 expression in hepatocellular carcinoma.

Authors:  Jun Lu; Xing-Zhizi Wang; Tian-Qi Zhang; Xiao-Ying Huang; Jin-Guang Yao; Chao Wang; Zhong-Hong Wei; Yun Ma; Xue-Min Wu; Chun-Ying Luo; Qiang Xia; Xi-Dai Long
Journal:  Oncotarget       Date:  2017-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.